Policy Briefings

Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know

MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales

China Aims for 25% of Global First-in-Class Drugs by 2030

White House Secures $19.6B in Pharma Manufacturing Pledges

Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit

Warren, Scott revive bill to map foreign control of US drug supply

Congress Proposes Federal Oversight for US-China Drug Licensing Deals

FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head

Trump Confirms Makary Exit; Diamantas Named Acting Chief

Regeneron Closes MFN Deal; Offers Gene Therapy Free

US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact

The European Biotech Act, Explained

Multistate Lawsuit Targets CDC Childhood Vaccine Rollback

Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next

FDA and EMA Issue Joint AI Principles for Drug Development

EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For

TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?

J&J Strikes Drug Pricing Deal with Trump Administration

Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing

US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds

Trump Administration Launches Review of Global Drug Pricing Practises

Morepen Laboratories Submits First ANDA for Sitagliptin Tablets

Vetter Expands Fill-and-Finish Network With 10 New Commercial Lines

Minaris Partners With Asimov to Advance AAV Producer Cell Lines

Altasciences Advances 4B Healthcare’s RhineX Into Clinical Testing

SK pharmteco Launches Catalyst Kit for Continuous API Manufacturing

SK pharmteco Supports GEMMABio’s Phase 1/2 Trial of SMA1 Gene Therapy

FamiCord AG Signs Manufacturing Agreement With VERIGRAFT for P-TEV

Altruist Biologics Suzhou Facility Passes EMA GMP Inspection

Recipharm Partners With CanVirex to Scale Oncolytic Measles Virus Manufacturing

Flen Health Selects AGC Biologics for Wound Therapy Manufacturing

Cellares Partners With SNUH on Automated PNH Cell Therapy Manufacturing

KinetiSol Receives FDA Advanced Manufacturing Technology Designation

Corealis Pharma Partners With PhinC Group on Oral Drug Development

Sharp Services Expands Autoinjector and Pen Assembly Capacity

Sanner Rebrands Gilero and Expands Chicago Innovation Facility

WuXi XDC Marks GMP Release of 25,000-Sq.-Meter Singapore Site

Made Scientific Acquires 85,000-Sq.-Ft. Cell Therapy Manufacturing Facility

Bespak and Upperton Partner on Nasal Drug Development and Manufacturing

European CDMO Landscape 2025: Download the latest edition